Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
AstraZeneca And Incyte Announce New Lung Cancer Clinical Trial Collaboration
AstraZeneca and Incyte Corporation today announced a new collaboration to evaluate the efficacy and safety of Incyte’sJanus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination wit...
Immune Pharmaceuticals Announces 2016 Immuno-Oncology Plan
NEW YORK, Jan.
Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development Program
KENILWORTH, NJ, USA I January 11, 2016 I Merck (NYSE.
Good Bacteria May Help Prevent Pneumonia, Says New Study
NEW YORK.
Sanofi and Regeneron line up for FDA approval with an arthritis treatment
Sanofi ($SNY) and Regeneron ($REGN) are moving toward FDA approval with what could be their second blockbuster collaboration, preparing to make the case for a new treatment for rheumat...
Mylan Announces Worldwide Collaboration with Momenta to Jointly Develop and Commercialize Six Biosimilar Products
HERTFORDSHIRE, England and PITTSBURGH, Jan.
Takeda and NsGene Partner to Perform Research in Cell Encapsulation Therapies for Parkinson's Disease
Osaka, Japan, January 8, 2016, and Providence, RI; January 7, 2016 – Takeda Pharmaceutical Company Limited (TSE.
Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection
SofosbuvirVelpatasvirFOSTER CITY, Calif.
54
55
56
57
58
